Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors

NCT04972110 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
156
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decided to terminate study early therefore, the Phase 2 portion was not conducted

Conditions

Interventions

Sponsor

Repare Therapeutics